HomeNewsBusinessMarketsChina is a good cyclical market to play; India still most expensive relative to other EMs

China is a good cyclical market to play; India still most expensive relative to other EMs

Arjun Divecha, Partner and Head of Emerging Markets for GMO, thinks India is still expensive while China is well-placed for a cyclical rebound

March 11, 2025 / 08:48 IST
Story continues below Advertisement
China is a good cyclical market to play; India still most expensive market relative to other EMs
China is a good cyclical market to play; India still most expensive market relative to other EMs

Arjun Divecha, Partner and Head of Emerging Markets at Boston-based investment firm GMO, is in the middle of roadshows across North America for his newly launched fund, 'Beyond China'. The fund aims to invest in countries benefiting from the “China plus one” supply chain diversification strategy. Given that India stands to gain from this long-term trend, the fund will include Indian investments—despite Divecha currently holding zero weight in India across his emerging market portfolios, primarily due to high valuations.  In a free-wheeling conversation, Divecha talks about his new fund, his take on India Vs China, foreign selling and Trump policies.

Edited excerpts:

Story continues below Advertisement

What is the idea behind GMO's latest launch, the 'Beyond China' ETF?

It's an active ETF which trades on the New York Stock Exchange. The basic thesis is that people, countries and companies are moving supply chains out of China. One, because of trade tensions with the U.S. and other countries. Two, because of the tensions in the Taiwan Strait. Three, because labour costs have become really high in China. And four, during Covid, people (companies) realised that they didn’t want to be dependent on one supplier.